Literature DB >> 33974730

Albumin Conjugates of Thiosemicarbazone and Imidazole-2-thione Prochelators: Iron Coordination and Antiproliferative Activity.

Yu-Shien Sung1, Wangbin Wu1, Megan A Ewbank1, Rachel D Utterback1, Michael T Marty1, Elisa Tomat1.   

Abstract

The central role of iron in tumor progression and metastasis motivates the development of iron-binding approaches in cancer chemotherapy. Disulfide-based prochelators are reductively activated upon cellular uptake to liberate thiol chelators responsible for iron sequestration. Herein, a trimethyl thiosemicarbazone moiety and the imidazole-2-thione heterocycle are incorporated in this prochelator design. Iron binding of the corresponding tridentate chelators leads to the stabilization of a low-spin ferric center in 2 : 1 ligand-to-metal complexes. Native mass spectrometry experiments show that the prochelators form stable disulfide conjugates with bovine serum albumin, thus affording novel bioconjugate prochelator systems. Antiproliferative activities at sub-micromolar levels are recorded in a panel of breast, ovarian and colorectal cancer cells, along with significantly lower activity in normal fibroblasts.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  albumin; cancer; imidazole-2-thione; iron chelation; thiosemicarbazone

Mesh:

Substances:

Year:  2021        PMID: 33974730      PMCID: PMC8448912          DOI: 10.1002/cmdc.202100278

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.540


  38 in total

1.  Effect of Carboxamido N Coordination to Iron on the Redox Potential of Low-Spin Non-Heme Iron Centers with N,S Coordination: Relevance to the Iron Site of Nitrile Hydratase.

Authors:  Juan C. Noveron; Marilyn M. Olmstead; Pradip K. Mascharak
Journal:  Inorg Chem       Date:  1998-03-23       Impact factor: 5.165

2.  Synthesis and biological activity of water-soluble maleimide derivatives of the anticancer drug carboplatin designed as albumin-binding prodrugs.

Authors:  André Warnecke; Iduna Fichtner; Dirk Garmann; Ulrich Jaehde; Felix Kratz
Journal:  Bioconjug Chem       Date:  2004 Nov-Dec       Impact factor: 4.774

3.  Thiol disulfide exchange reactions in human serum albumin: the apparent paradox of the redox transitions of Cys34.

Authors:  Alessio Bocedi; Giada Cattani; Lorenzo Stella; Renato Massoud; Giorgio Ricci
Journal:  FEBS J       Date:  2018-08-02       Impact factor: 5.542

4.  Synthesis, characterization, DFT calculations, and electrochemical comparison of novel iron(ii) complexes with thione and selone ligands.

Authors:  Bradley S Stadelman; Martin M Kimani; Craig A Bayse; Colin D McMillen; Julia L Brumaghim
Journal:  Dalton Trans       Date:  2016-02-09       Impact factor: 4.390

5.  Iron Complexes of an Antiproliferative Aroyl Hydrazone: Characterization of Three Protonation States by Electron Paramagnetic Resonance Methods.

Authors:  Andrei V Astashkin; Rachel D Utterback; Yu-Shien Sung; Elisa Tomat
Journal:  Inorg Chem       Date:  2020-07-30       Impact factor: 5.165

6.  Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells.

Authors:  Angelica M Merlot; Sumit Sahni; Darius J R Lane; Ashleigh M Fordham; Namfon Pantarat; David E Hibbs; Vera Richardson; Munikumar R Doddareddy; Jennifer A Ong; Michael L H Huang; Des R Richardson; Danuta S Kalinowski
Journal:  Oncotarget       Date:  2015-04-30

7.  Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression.

Authors:  Christina Mertens; Eman Abureida Akam; Claudia Rehwald; Bernhard Brüne; Elisa Tomat; Michaela Jung
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

8.  Iron addiction: a novel therapeutic target in ovarian cancer.

Authors:  D Basuli; L Tesfay; Z Deng; B Paul; Y Yamamoto; G Ning; W Xian; F McKeon; M Lynch; C P Crum; P Hegde; M Brewer; X Wang; L D Miller; N Dyment; F M Torti; S V Torti
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

9.  The Disturbed Iron Phenotype of Tumor Cells and Macrophages in Renal Cell Carcinoma Influences Tumor Growth.

Authors:  Matthias Schnetz; Julia K Meier; Claudia Rehwald; Christina Mertens; Anja Urbschat; Elisa Tomat; Eman A Akam; Patrick Baer; Frederik C Roos; Bernhard Brüne; Michaela Jung
Journal:  Cancers (Basel)       Date:  2020-02-25       Impact factor: 6.639

Review 10.  Targeting iron metabolism in drug discovery and delivery.

Authors:  Bart J Crielaard; Twan Lammers; Stefano Rivella
Journal:  Nat Rev Drug Discov       Date:  2017-02-03       Impact factor: 84.694

View more
  1 in total

1.  Aroylhydrazone Glycoconjugate Prochelators Exploit Glucose Transporter 1 (GLUT1) to Target Iron in Cancer Cells.

Authors:  Yu-Shien Sung; Baris Kerimoglu; Aikseng Ooi; Elisa Tomat
Journal:  ACS Med Chem Lett       Date:  2022-08-18       Impact factor: 4.632

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.